首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:The innovation

缩写:

ISSN:2666-6758

e-ISSN:2666-6758

IF/分区:25.7/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引789
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Qi Peng,Ruchao Peng,Bin Yuan et al. Qi Peng et al.
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has developed into an unprecedented global pandemic. Nucleoside analogs, such as Remdesivir and Favipiravir, can serve as the first-line broad-spectrum antiviral d...
Lei Zhang,Mingwang Shen,Xiaomeng Ma et al. Lei Zhang et al.
Background: The Chinese government implemented a metropolitan-wide quarantine of Wuhan city on 23rd January 2020 to curb the epidemic of the coronavirus COVID-19. Lifting of this quarantine is imminent. We modelled the ef...
Rong Wang,Yuankang Xiong,Xiaofan Xing et al. Rong Wang et al.
Lockdown measures are essential to containing the spread of coronavirus disease 2019 (COVID-19), but they will slow down economic growth by reducing industrial and commercial activities. However, the benefits of activity control from contai...
Yang Yang,Minghui Yang,Jing Yuan et al. Yang Yang et al.
The worldwide epidemic of coronavirus disease 2019 (COVID-19) is ongoing. Rapid and accurate detection of the causative virus SARS-CoV-2 is vital for the treatment and control of COVID-19. In this study, the comparative sensitivity of diffe...
Hong-Tian Li,Zhi-Hao Cheng,Yong-Ying Huang et al. Hong-Tian Li et al.
[This corrects the article DOI: 10.1016/j.xinn.2020.100028.]. © 2020.
Donghai Liang,Liuhua Shi,Jingxuan Zhao et al. Donghai Liang et al.
Background: The novel human coronavirus disease 2019 (COVID-19) pandemic has claimed more than 600,000 lives worldwide, causing tremendous public health, social, and economic damages. Although the risk factors of COVID-19...
Delong Jiao,Shengyu Yang Delong Jiao
Activating KRAS mutations are present in 25% of human cancer. Although oncogenic Ras was deemed "undruggable" in the past, recent efforts led to the development of pharmacological inhibitors targeting the KRASG12C mutant, which have shown p...